To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"Now that we know that we can target the basic molecular defects in Alzheimer's disease, we can hope for treatments far better—and more specific—than anything we have today." -Dr. Gerald Weissmann

A new ray of hope has broken through the clouded outcomes associated with Alzheimer's disease. A new research report published in January 2013 print issue of the FASEB Journal (Federation of the American Societies for Experimental Biology) by scientists from the National Institutes of Health shows that when a molecule called TFP5 is injected into mice with disease that is the equivalent of human Alzheimer's, symptoms are reversed and memory is restored—without obvious toxic side effects.

"We hope that clinical trial studies in AD patients should yield an extended and a better quality of life as observed in mice upon TFP5 treatment," said Harish C. Pant, Ph.D., a senior researcher involved in the work from the Laboratory of Neurochemistry at the National Institute of Neurological Disorders at Stroke at the National Institutes of Health in Bethesda, MD. "Therefore, we suggest that TFP5 should be an effective therapeutic compound." (Photo by: Cécile Graat)

To make this discovery, Pant and colleagues used mice with a disease considered the equivalent of Alzheimer's. One set of these mice were injected with the small molecule TFP5, while the other was injected with saline as placebo. The mice, after a series of intraperitoneal injections of TFP5, displayed a substantial reduction in the various disease symptoms along with restoration of memory loss. In addition, the mice receiving TFP5 injections experienced no weight loss, neurological stress (anxiety) or signs of toxicity. The disease in the placebo mice, however, progressed normally as expected. TFP5 was derived from the regulator of a key brain enzyme, called Cdk5. The over activation of Cdk5 is implicated in the formation of plaques and tangles, the major hallmark of Alzheimer's disease.

"The next step is to find out if this molecule can have the same effects in people, and if not, to find out which molecule will," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal. "Now that we know that we can target the basic molecular defects in Alzheimer's disease, we can hope for treatments far better—and more specific—than anything we have today."

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Cracker Barrel CEO Julie Masino Steps Down After 'Woke' Rebranding Backlash

WNBA's Sophie Cunningham Backs Young Fans after Seattle Storm Co-Owner Cursed Them Out for Supporting Biological Reality (Video)

Christian PA Who Was Fired Over Transgender Referrals, Pronouns Wins $410K Settlement as Hospital Adopts New Policy

Boy George Chooses Truth Over the Anti-Israel Mob

Netanyahu Tells Christians: 'We Are One' (Video)

Florida Announces Investigation into Fauci Since His Pardon Isn't for State Charges

Prayer Alert: The First Lady and Barron Are Now in Iran's Crosshairs

DHS Arrested Over 900 Human Trafficking Suspects and Rescued 180 Victims during FIFA World Cup

Florida Evangelist Turning Defunct Vermont Campus into 'Christ-Centered University'

GenderSpeak: Weaponizing Gender Against Sex

Medical Schools Accused of Renaming DEI Offices to Avoid Scrutiny

Trump Administration Formally Bans Dangerous Gain-of-function Research

New Jersey Governor Refuses Noncitizen Voters' Data to Trump Administration, Calls Aliens 'Citizens'

Rand Paul Delivers a Cinematic Indictment of Anthony Fauci's COVID Legacy, While Fauci Pleads the Fifth (Video)

Islamic Regime in Iran Stage Public Executions of Innocent Protesters; Crickets from the UN and Human Rights Groups

Netanyahu Praises 'Excellent' Trump Meeting; IRGC Launches Surprise Attack on US Forces

'Craving the Truth': The Shocking Spiritual Hunger Sweeping Gen Z (Video)

'Unprecedented': AI Agent Escapes Secured Testing Environment and Hacks Another AI

University of Minnesota Medical School Develops Taxpayer-Funded 'Transgender' Dolls for Preschoolers

Trump Administration Asks Supreme Court to Allow Mail-in Ballot Restrictions

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor